Chlamydia-Induced Reactive Arthritis: Disappearing Entity or Lack of Research?

Area of Science:

• Rheumatology
• Infectious Diseases
• Public Health

Background:

• Reactive arthritis (ReA) is a form of inflammatory arthritis.
• Chlamydia trachomatis is a common cause of sexually transmitted infections and can lead to ReA.
• The incidence of Chlamydia-associated ReA has been debated, with some regions reporting declining rates.

Purpose of the Study:

• To review recent studies on the frequency of Chlamydia-induced reactive arthritis (ReA).
• To investigate whether Chlamydia-associated ReA is decreasing or being underdiagnosed/underreported.
• To assess the role of early antibiotic treatment in preventing Chlamydia-associated ReA.

Main Methods:

• Systematic review of epidemiological reports and recent studies.
• Analysis of data on the incidence and prevalence of Chlamydia-associated ReA globally.
• Evaluation of clinical evidence regarding the impact of early antibiotic treatment.

Main Results:

• Epidemiological data show varied frequencies of Chlamydia-associated ReA worldwide.
• Some regions report a declining incidence of Chlamydia-associated ReA.
• ReA secondary to Lymphogranuloma venereum (LGV) serovars L1-L3 of C. trachomatis may be underestimated due to low awareness and changing clinical presentations.

Conclusions:

• The apparent decline in Chlamydia-associated ReA may be due to underdiagnosis and underreporting rather than a true decrease in incidence.
• Further research is needed to confirm if early antibiotic treatment can prevent Chlamydia-associated ReA.
• Increased awareness of LGV-associated ReA is crucial, especially given its re-emergence and atypical presentations.